Bio-Rad's Q4 Revenues Increase 10 Percent on Strong Life Science, Dx Sales

Bio-Rad's life sciences and clinical diagnostics segments both contributed double-digit revenue increases for the quarter.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories